Published in Genetics on February 16, 2005
Genome Reshuffling for Advanced Intercross Permutation (GRAIP): simulation and permutation for advanced intercross population analysis. PLoS One (2008) 1.33
Alternative splicing and transcriptome profiling of experimental autoimmune encephalomyelitis using genome-wide exon arrays. PLoS One (2009) 0.88
Identification of candidate risk gene variations by whole-genome sequence analysis of four rat strains commonly used in inflammation research. BMC Genomics (2014) 0.79
Fine-mapping QTLs in advanced intercross lines and other outbred populations. Mamm Genome (2014) 0.77
Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity. Hum Mol Genet (2013) 0.77
Identifying genes for neurobehavioural traits in rodents: progress and pitfalls. Dis Model Mech (2017) 0.75
Gene expression profiling as a tool for positional cloning of genes-shortcut or the longest way round. Curr Genomics (2008) 0.75
Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics (1989) 79.44
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet (1995) 49.77
Empirical threshold values for quantitative trait mapping. Genetics (1994) 46.95
R/qtl: QTL mapping in experimental crosses. Bioinformatics (2003) 22.38
Simplified mammalian DNA isolation procedure. Nucleic Acids Res (1991) 12.56
Advanced intercross lines, an experimental population for fine genetic mapping. Genetics (1995) 5.69
A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature (1995) 3.57
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A (1998) 3.35
A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet (1996) 3.00
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet (1996) 2.98
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol (1988) 2.93
Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A (2000) 2.82
A population-based study of multiple sclerosis in twins. N Engl J Med (1986) 2.59
Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today (1997) 2.49
Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet (2002) 2.46
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet (1973) 2.41
A simple method to calculate resolving power and confidence interval of QTL map location. Behav Genet (1997) 2.37
The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A (2001) 2.30
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med (2001) 2.27
A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet (1995) 2.10
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens (1991) 1.80
Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet (1996) 1.77
New target regions for human hypertension via comparative genomics. Genome Res (2000) 1.75
The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol (1995) 1.71
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol (1991) 1.65
Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest (1993) 1.62
Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet (1997) 1.57
A population-based study of multiple sclerosis in twins: update. Ann Neurol (1993) 1.46
MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest (1998) 1.33
Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases. J Immunol (1998) 1.15
Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet (1995) 1.15
Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol (1995) 1.10
The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain (1998) 1.07
Fine-scale mapping of quantitative trait loci using historical recombinations. Genetics (1997) 1.06
An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J Immunol (2004) 1.03
A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun (2002) 1.01
Multiple susceptibility loci for multiple sclerosis. Hum Mol Genet (2002) 1.01
Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Immunogenetics (2001) 0.95
A genome screen for multiple sclerosis in Sardinian multiplex families. Eur J Hum Genet (2001) 0.91
Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis. Eur J Immunol (1998) 0.90
A genome screen for multiple sclerosis in Italian families. Genes Immun (2001) 0.89
Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum Mol Genet (1999) 0.89
A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun (2002) 0.88
Identification of quantitative trait loci for serum cholesterol levels in stroke-prone spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol (2000) 0.82
Genetic epidemiology of multiple sclerosis. Curr Opin Neurol (1996) 0.82
Current gene-mapping strategies in experimental models of multiple sclerosis. Scand J Immunol (2004) 0.81
Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J Immunol (1999) 0.80
Chromosomal mapping of genes controlling development, histological grade, depth of invasion, and size of rat stomach carcinomas. Cancer Res (2000) 0.80
Paradoxical effects of arthritis-regulating chromosome 4 regions on myelin oligodendrocyte glycoprotein-induced encephalomyelitis in congenic rats. Eur J Immunol (2003) 0.78
Polygenic control of autoimmune peripheral nerve inflammation in rat. J Neuroimmunol (2001) 0.78
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature (2003) 13.00
Progress and prospects in rat genetics: a community view. Nat Genet (2008) 6.01
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet (2007) 4.22
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol (2003) 2.80
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet (2007) 2.54
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann Neurol (2010) 2.40
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet (2005) 2.32
An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform. Epigenetics (2013) 2.28
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain (2011) 2.24
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr (2012) 2.10
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology (2012) 2.09
Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med (2009) 2.02
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes. Mult Scler (2013) 1.95
Management of postpolio syndrome. Lancet Neurol (2010) 1.94
A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes (2005) 1.94
Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med (2007) 1.77
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study. Lancet Neurol (2013) 1.76
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler (2012) 1.64
Shift work at young age is associated with increased risk for multiple sclerosis. Ann Neurol (2011) 1.63
Changes to anti-JCV antibody levels in a Swedish national MS cohort. J Neurol Neurosurg Psychiatry (2013) 1.63
Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheum Dis (2012) 1.59
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response. PLoS One (2013) 1.57
Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet (2013) 1.55
Prior poliomyelitis-evidence of cytokine production in the central nervous system. J Neurol Sci (2002) 1.54
Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology (2014) 1.54
Neonatal vitamin D status and risk of multiple sclerosis. Ann Neurol (2014) 1.54
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology (2009) 1.51
Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet (2008) 1.47
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler (2012) 1.46
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Mult Scler (2010) 1.46
Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes (2012) 1.44
Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis. Neurology (2012) 1.42
Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival. Leuk Lymphoma (2009) 1.40
Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med (2005) 1.31
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats. Nat Genet (2013) 1.30
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol (2013) 1.27
CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J Neuroinflammation (2005) 1.27
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression. PLoS One (2013) 1.21
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. Mult Scler (2011) 1.21
Genome wide association study identifies KCNMA1 contributing to human obesity. BMC Med Genomics (2011) 1.18
Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nat Genet (2010) 1.16
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J Neuroinflammation (2007) 1.15
Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation. Mol Cell Biol (2009) 1.14
A resource for the simultaneous high-resolution mapping of multiple quantitative trait loci in rats: the NIH heterogeneous stock. Genome Res (2008) 1.13
Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol (2008) 1.12
Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis. Eur J Neurosci (2006) 1.11
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity. Proc Natl Acad Sci U S A (2013) 1.07
Expression of six transmembrane protein of prostate 2 in human adipose tissue associates with adiposity and insulin resistance. J Clin Endocrinol Metab (2008) 1.07
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain (2012) 1.06
Parental age, family size, and risk of multiple sclerosis. Epidemiology (2004) 1.06
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Eur J Hum Genet (2009) 1.05
TLR activation induces TNF-alpha production from adult neural stem/progenitor cells. J Immunol (2009) 1.05
An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J Immunol (2004) 1.03
The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls. Genome Med (2012) 1.03
Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation. Sci Transl Med (2012) 1.01
Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J Clin Endocrinol Metab (2013) 1.00
Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery? Neurobiol Dis (2009) 0.99
IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation. J Immunol (2010) 0.99
Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet (2010) 0.99
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol (2014) 0.99
Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J Immunol (2004) 0.99
Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. Lancet Neurol (2006) 0.99
Immunological patterns identifying disease course and evolution in multiple sclerosis patients. J Neuroimmunol (2005) 0.97
A possible inflammatory role of twist1 in human white adipocytes. Diabetes (2009) 0.97
Liver X receptor (LXR) regulates human adipocyte lipolysis. J Biol Chem (2010) 0.97
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis. Mult Scler (2012) 0.97
Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease. Hum Mol Genet (2012) 0.96
Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatibility complex (MHC) haplotype-related. J Neuropathol Exp Neurol (2006) 0.96
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler (2013) 0.96
Differential effects of 1α,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur J Nutr (2011) 0.95
Role of follistatin in promoting adipogenesis in women. J Clin Endocrinol Metab (2009) 0.95
MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia. Am J Physiol Endocrinol Metab (2013) 0.95
Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats. PLoS One (2012) 0.95
Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4-/- and CD8-/- DBA/1 mice defines qualitative roles of different T cell subsets. J Neuroimmunol (2003) 0.94
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments. Mol Cell Proteomics (2013) 0.94
Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study. PLoS One (2012) 0.93
Profound and paradoxical impact on arthritis and autoimmunity of the rat antigen-presenting lectin-like receptor complex. Arthritis Rheum (2008) 0.93
Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann Rheum Dis (2011) 0.93